Lee's Pharmaceutical Holdings (0950.HK) Earnings Analysis
Lee's Pharmaceutical Holdings (0950.HK) next reports earnings on 2026-09-02. Trailing P/E 7.56.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 0950.HK next report earnings?
| Next earnings date | 2026-09-02 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | n/a |
0950.HK earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-25 | 0.021 HKD | n/a | n/a | n/a |
| 2025-08-26 | 0.05705 HKD | n/a | n/a | n/a |
| 2025-03-24 | 0.026 HKD | n/a | n/a | n/a |
| 2024-08-28 | 0.05305 HKD | n/a | n/a | n/a |
0950.HK valuation and analyst view
| Trailing P/E | 7.56 |
|---|---|
| Trailing EPS | 0.15608 HKD |
| Price / book | 0.34 |
| Dividend yield | 3.81% |
| Market cap | 0.69B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Lee's Pharmaceutical Holdings (0950.HK)'s next earnings date?
Lee's Pharmaceutical Holdings is next scheduled to report on 2026-09-02.
Did 0950.HK beat earnings last quarter?
Consensus estimate data was not available for 0950.HK's 2026-03-25 report.
What is 0950.HK's current P/E ratio and EPS?
0950.HK trades at a trailing P/E of 7.56 on trailing EPS of 0.1560788041811009 HKD.
What do analysts rate 0950.HK?
0950.HK has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.